VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells

Journal of Cell Science

Volumn 124, Issue 11, 2011, Pages 1819-1830

  Bekhite, Mohamed M ^a,b   Finkensieper, Andreas ^a   Binas, Stephanie ^a   Müller, Jörg ^a   Wetzker, Reinhard ^a   Figulla, Hans Reiner ^a   Sauer, Heinrich ^c   Wartenberg, Maria ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Tanta University   (Egypt)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cardiovascular differentiation; Embryonic stem cells; Phosphoinositide 3 kinase; Protein kinase C

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN INHIBITOR; PROTEIN KINASE C; ROTTLERIN; SHORT HAIRPIN RNA; VASCULOTROPIN; WORTMANNIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARDIOMYOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; GENE SILENCING; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CATALYTIC DOMAIN; CELL DIFFERENTIATION; CELL LINE; CHROMONES; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; EMBRYOID BODIES; ENZYME ACTIVATION; MICE; MORPHOLINES; MUSCLE DEVELOPMENT; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79958145723     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.077594     Document Type: Article

References (52)

1. Abid, M. R., Guo, S., Minami, T., Spokes, K. C., Ueki, K., Skurk, C., Walsh, K. and Aird, W. C. (2004). Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24, 294-300.
2. Bekhite, M. M., Finkensieper, A., Abou-Zaid, F. A., El Shourbagy, I. K., Omar, K. M., Figulla, H. R., Sauer, H. and Wartenberg, M. (2010). Static electromagnetic fields induce vasculogenesis and chondro-osteogenesis of mouse embryonic stem cells by reactive oxygen species-mediated upregulation of vascular endothelial growth factor. Stem Cells Dev. 19, 731-743.
3. Bos, J. L. (1995). A target for phosphoinositide 3-kinase: Akt/PKB. Trends Biochem. Sci. 20, 441-442.
4. Bu, L., Jiang, X., Martin-Puig, S., Caron, L., Zhu, S., Shao, Y., Roberts, D. J., Huang, P. L., Domian, I. J. and Chien, K. R. (2009). Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460, 113-117.
5. Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
6. Chen, Y., Amende, I., Hampton, T. G., Yang, Y., Ke, Q., Min, J. Y., Xiao, Y. F. and Morgan, J. P. (2006). Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells. Am. J. Physiol. Heart Circ. Physiol. 291, H1653-H1658.
7. Cheung, C. Y. (1997). Vascular endothelial growth factor: possible role in fetal development and placental function. J. Soc. Gynecol. Investig. 4, 169-177.
8. Chou, M. M., Hou, W., Johnson, J., Graham, L. K., Lee, M. H., Chen, C. S., Newton, A. C., Schaffhausen, B. S. and Toker, A. (1998). Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr. Biol. 8, 1069-1077.
9. Cross, M. J., Dixelius, J., Matsumoto, T. and Claesson-Welsh, L. (2003). VEGFreceptor signal transduction. Trends Biochem. Sci. 28, 488-494.
10. Dutil, E. M., Toker, A. and Newton, A. C. (1998). Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 8, 1366-1375.
11. Ferrara, N. (1999). Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77, 527-543.
12. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
13. Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R. N. and Walsh, K. (2000). Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101, 660-667.
14. Garry, D. J. and Olson, E. N. (2006). A common progenitor at the heart of development. Cell 127, 1101-1104.
15. Gerasimovskaya, E. V., Tucker, D. A. and Stenmark, K. R. (2005). Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation. J. Appl. Physiol. 98, 722-731.
16. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V. and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-30343.
17. Gliki, G., Wheeler-Jones, C. and Zachary, I. (2002). Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3′-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis. Cell Biol. Int. 26, 751-759.
18. Hamada, K., Sasaki, T., Koni, P. A., Natsui, M., Kishimoto, H., Sasaki, J., Yajima, N., Horie, Y., Hasegawa, G., Naito, M. et al. (2005). The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev. 19, 2054-2065.
19. Hayakawa, M., Kaizawa, H., Moritomo, H., Koizumi, T., Ohishi, T., Okada, M., Ohta, M., Tsukamoto, S., Parker, P., Workman, P. et al. (2006). Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg. Med. Chem. 14, 6847-6858.
20. Iida, M., Heike, T., Yoshimoto, M., Baba, S., Doi, H. and Nakahata, T. (2005). Identification of cardiac stem cells with FLK1, CD31, and VE-cadherin expression during embryonic stem cell differentiation. FASEB J. 19, 371-378.
21. Jackson, S. P., Schoenwaelder, S. M., Goncalves, I., Nesbitt, W. S., Yap, C. L., Wright, C. E., Kenche, V., Anderson, K. E., Dopheide, S. M., Yuan, Y. et al. (2005). PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat. Med. 11, 507-514.
22. Jiang, B. H., Zheng, J. Z., Aoki, M. and Vogt, P. K. (2000). Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97, 1749-1753.
23. Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J. and Waterfield, M. D. (2001). Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17, 615-675.
24. Kattman, S. J., Huber, T. L. and Keller, G. M. (2006). Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11, 723-732.
25. Kattman, S. J., Adler, E. D. and Keller, G. M. (2007). Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Trends Cardiovasc. Med. 17, 240-246.
26. Klinz, F., Bloch, W., Addicks, K. and Hescheler, J. (1999). Inhibition of phosphatidylinositol-3-kinase blocks development of functional embryonic cardiomyocytes. Exp. Cell Res. 247, 79-83.
27. Lange, S., Heger, J., Euler, G., Wartenberg, M., Piper, H. M. and Sauer, H. (2009). Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cellderived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovasc. Res. 81, 159-168.
28. Le Good, J. A., Ziegler, W. H., Parekh, D. B., Alessi, D. R., Cohen, P. and Parker, P. J. (1998). Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042-2045.
29. Lee, K. S., Lee, H. K., Hayflick, J. S., Lee, Y. C. and Puri, K. D. (2006). Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J. 20, 455-465.
30. Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S. et al. (2005). Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol. Cell. Biol. 25, 9491-9502.
31. Matsui, T., Li, L., del Monte, F., Fukui, Y., Franke, T. F., Hajjar, R. J. and Rosenzweig, A. (1999). Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100, 2373-2379.
32. Qi, J. H. and Claesson-Welsh, L. (2001). VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. Exp. Cell Res. 263, 173-182.
33. Sauer, H., Rahimi, G., Hescheler, J. and Wartenberg, M. (2000). Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. FEBS Lett. 476, 218-223.
34. Sauer, H., Bekhite, M. M., Hescheler, J. and Wartenberg, M. (2005). Redox control of angiogenic factors and CD31-positive vessel-like structures in mouse embryonic stem cells after direct current electrical field stimulation. Exp. Cell Res. 304, 380-390.
35. Sauer, H., Ruhe, C., Muller, J. P., Schmelter, M., D'Souza, R. and Wartenberg, M. (2008). Reactive oxygen species and upregulation of NADPH oxidases in mechanotransduction of embryonic stem cells. Methods Mol. Biol. 477, 397-418.
36. Schambach, A., Galla, M., Modlich, U., Will, E., Chandra, S., Reeves, L., Colbert, M., Williams, D. A., von Kalle, C. and Baum, C. (2006). Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. Exp. Hematol. 34, 588-592.
37. Shioi, T., Kang, P. M., Douglas, P. S., Hampe, J., Yballe, C. M., Lawitts, J., Cantley, L. C. and Izumo, S. (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19, 2537-2548.
38. Shiojima, I. and Walsh, K. (2002). Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90, 1243-1250.
39. Shiojima, I. and Walsh, K. (2006). Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20, 3347-3365.
40. Song, Y. H., Gehmert, S., Sadat, S., Pinkernell, K., Bai, X., Matthias, N. and Alt, E. (2007). VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 354, 999-1003.
41. Stephens, L. R., Hughes, K. T. and Irvine, R. F. (1991). Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils. Nature 351, 33-39.
42. Teicher, B. A. (2006). Protein kinase C as a therapeutic target. Clin. Cancer Res 12, 5336-5345.
43. Thakker, G. D., Hajjar, D. P., Muller, W. A. and Rosengart, T. K. (1999). The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J. Biol. Chem. 274, 10002-10007.
44. Thomas, M. and Owen, C. (2008). Inhibition of PI-3 kinase for treating respiratory disease: good idea or bad idea?. Curr. Opin. Pharmacol. 8, 267-274.
45. Vanhaesebroeck, B., Leevers, S. J., Panayotou, G. and Waterfield, M. D. (1997). Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22, 267-272.
46. Wang, S., Li, X., Parra, M., Verdin, E., Bassel-Duby, R. and Olson, E. N. (2008). Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc. Natl. Acad. Sci. USA 105, 7738-7743.
47. Whitman, M., Downes, C. P., Keeler, M., Keller, T. and Cantley, L. (1988). Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332, 644-646.
48. Wymann, M. P. and Pirola, L. (1998). Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta 1436, 127-150.
49. Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M. et al. (2008). Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524-528.
50. Yang, Y., Min, J. Y., Rana, J. S., Ke, Q., Cai, J., Chen, Y., Morgan, J. P. and Xiao, Y. F. (2002). VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J. Appl. Physiol. 93, 1140-1151.
51. Yuan, T. L., Choi, H. S., Matsui, A., Benes, C., Lifshits, E., Luo, J., Frangioni, J. V. and Cantley, L. C. (2008). Class 1A PI3K regulates vessel integrity during development and tumorigenesis. Proc. Natl. Acad. Sci. USA 105, 9739-9744.
52. Zisa, D., Shabbir, A., Suzuki, G. and Lee, T. (2009). Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cellmediated cardiac repair. Biochem. Biophys. Res. Commun. 390, 834-838.